ストックスクリーナーアプリを入手
85.73
0.51%
-0.44
前日終値:
$86.17
開ける：
$86.31
24時間の取引高:
8.51M
Relative Volume:
1.11
時価総額：
$112.76B
収益：
$33.54B
当期純損益:
$4.66B
株価収益率:
23.68
EPS:
3.62
ネットキャッシュフロー:
$5.19B
1週間 パフォーマンス:
-2.65%
1か月 パフォーマンス:
-0.82%
6か月 パフォーマンス:
+7.12%
1年 パフォーマンス:
+7.50%
1日の値動き範囲:
$85.41
$86.40
1週間の範囲:
$85.41
$88.77
52週間の値動き範囲:
$75.96
$96.25
Medtronic Plc Stock (MDT) Company Profile
名前
Medtronic Plc
セクター
電話
01135314381700
住所
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
MDT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
85.73 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
ABT
Abbott Laboratories
|
132.41 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
101.37 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
373.26 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
EW
Edwards Lifesciences Corp
|
73.98 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-03-04 | アップグレード | Citigroup | Neutral → Buy |
| 2024-10-10 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 繰り返されました | Oppenheimer | Perform |
| 2024-08-15 | アップグレード | UBS | Sell → Neutral |
| 2024-08-14 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Sell |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | ダウングレード | UBS | Buy → Sell |
| 2023-01-09 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-11-23 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-11-16 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-08-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 開始されました | Wolfe Research | Underperform |
| 2022-06-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | ダウングレード | Needham | Buy → Hold |
| 2022-04-13 | ダウングレード | Truist | Buy → Hold |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-12-16 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-06-10 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-12-15 | アップグレード | Goldman | Sell → Neutral |
| 2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | アップグレード | Stifel | Hold → Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-05-14 | ダウングレード | DZ Bank | Buy → Hold |
| 2020-03-30 | ダウングレード | Needham | Strong Buy → Buy |
| 2020-03-25 | アップグレード | DZ Bank | Hold → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Sell |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2020-01-02 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-06-05 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 繰り返されました | Needham | Strong Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2019-01-02 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-12-19 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-08-27 | 繰り返されました | Argus | Buy |
すべてを表示
Medtronic Plc (MDT) 最新ニュース
Medtronic Diabetes and tennis pro Alexander Zverev join forces to champion life without limits for people with diabetes - Medtronic
Medtronic training pact includes Hugo robot, cardiac ablation tech - MedTech Dive
Medtronic stock has significant opportunity in renal denervation, RBC says By Investing.com - Investing.com UK
FDA Clears Minimally Invasive Laser Ablation System from Medtronic for Epilepsy & Brain Tumors - Medical Device and Diagnostic industry
Medtronic partners with IRCAD on Hugo, Affera surgical training - MassDevice
Medtronic to invest $50 million over five years in Pune GCC - BusinessLine
Medtronic : IRCAD North America and Medtronic announce collaboration to advance surgical training and innovation - MarketScreener
Surgical Retractors Market Top Companies StudyMedtronic Plc, - openPR.com
Medtronic to invest $50 million over 5 years in Pune - PUNE PULSE
Medtronic plc Stock MDT Using Cash Flow Model NYSE Composite - Kalkine Media
A Look At The Fair Value Of Medtronic plc (NYSE:MDT) - simplywall.st
Medtronic to invest $50 million over 5 years in New Diabetes Global Capability Centre in Pune - Punekar News
Medtronic Invests $50M in Pune Diabetes Center - Rediff MoneyWiz
Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings - Investing.com Nigeria
Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings By Investing.com - Investing.com South Africa
Leerink Partners Initiates Coverage on Medtronic (MDT) with Outperform Rating | MDT Stock News - GuruFocus
Medtronic (MDT) Positioned for Growth Amid Strategic Shifts | MDT Stock News - GuruFocus
Leerink Partners Initiates Medtronic at Outperform With $110 Price Target - MarketScreener
Medtronic: Solid Recent Performance But Better Options Available (NYSE:MDT) - Seeking Alpha
Medtronic Doubles Down on Innovation as Cardiovascular Tech Takes Center Stage! - Smartkarma
Medtronic’s SWOT analysis: stock outlook amid diabetes spin-off and RDN growth - Investing.com
Medtronic separate diabetes business to be called MiniMed - MSN
Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst - Benzinga
FDA approves Medtronic Omniasecure defib lead - BioWorld MedTech
Medtronic Plc. (NYSE: MDT) To Separate Its Diabetes Business - Smartkarma
Earnings Preview: What To Expect From Medtronic’s Report - MSN
Medtronic Diabetes Spinoff to Honor MiniMed Roots - Medical Device and Diagnostic industry
Medtronic (MDT) Revives MiniMed for Diabetes Spin-Off - GuruFocus
Medtronic recalls ventilators linked to 2 serious injuries, 1 death - MedTech Dive
Medtronic issues safety notice for Hugo surgical robot console in Europe - MassDevice
Medtronic announces MiniMed as name for planned New Diabetes Company - GuruFocus
Medtronic (MDT) Unveils "MiniMed" for Upcoming Diabetes Spinoff - GuruFocus
Medtronic's New Diabetes Company to Be Named MiniMed - MarketScreener
Medtronic announces MiniMed as name for planned New Diabetes Company | MDT Stock News - GuruFocus
Medtronic names planned diabetes spinoff company MiniMed - Investing.com
Medtronic names planned diabetes spinoff company MiniMed By Investing.com - Investing.com Canada
Medtronic Announces MiniMed As Name For Planned New Diabetes Company - marketscreener.com
FDA Upgrades Medtronic Recall Of Newport Ventilators To Class I - RTTNews
Medtronic Q4 Earnings and Revenues Top, Stock Down in Pre-market - MSN
Medtronic advises discontinuation of certain Newport ventilators after recall - MassDevice
Medtronic : announces voluntary recall of select Newport™ HT70 and Newport™ HT70 Plus ventilators and certain related Newport™ service parts - marketscreener.com
Medtronic : treats first U.S. patient in Global SYMPLICITY Registry DEFINE Study - marketscreener.com
5 Things You Need to Know If You Buy Medtronic Today - The Motley Fool
Medtronic names Kate Benedict president of acute care and monitoring - MedTech Dive
Medtronic appoints new president of Acute Care & Monitoring unit - MassDevice
Medtronic Announces Intent To Spin Diabetes Business - Forbes
Medtronic wins CE mark for VitalFlow ECMO system - MassDevice
Medtronic to separate diabetes business, WSJ reports - MSN
Medtronic's Separation of Diabetes Business May Drive Long-Term Value, Needham Says - marketscreener.com
Medtronic removes tracheostomy tubes due to dislodging risk - MedTech Dive
NEEDHAM ANALYST MAINTAINS HOLD RATING ON MEDTRONIC STOCK By Investing.com - Investing.com UK
Medtronic Plc (MDT) 財務データ
収益
当期純利益
現金流量
EPS
0.03%
0.97%
大文字化:
|
ボリューム (24 時間):